Taiyin Yang, PhD
Executive Vice President, Pharmaceutical Development and Manufacturing
Taiyin Yang serves as Executive Vice President of Pharmaceutical Development and Manufacturing with responsibility for all the company’s investigational compounds and marketed products. Under her leadership, Gilead developed the world’s first HIV single tablet regimen and advanced more than 25 compounds from early-stage development to market, reaching millions of people around the world.
Prior to joining Gilead in 1993, Taiyin worked in analytical chemistry at Syntex Corp.
She received her bachelor’s degree in chemistry from National Taiwan University and her PhD in organic chemistry from the University of Southern California.
-
Daniel O’Day
Chairman and Chief Executive Officer, Gilead Sciences, Inc.
-
Andrew Dickinson
Chief Financial Officer
-
Flavius Martin
Executive Vice President, Research
-
Jyoti Mehra
Executive Vice President, Human Resources
-
Johanna Mercier
Chief Commercial Officer
-
Merdad Parsey, MD, PhD
Chief Medical Officer
-
Brett A. Pletcher
Executive Vice President, Corporate Affairs and General Counsel
-
Christi Shaw
Chief Executive Officer, Kite
-
Taiyin Yang, PhD
Executive Vice President, Pharmaceutical Development and Manufacturing